Bill

Bill > HB1403


VA HB1403

VA HB1403
Health insurance; cost-sharing payments for prescription insulin drugs.


summary

Introduced
01/08/2020
In Committee
01/08/2020
Crossed Over
Passed
Dead
03/12/2020

Introduced Session

2020 Regular Session

Bill Summary

Health insurance; cost-sharing payments for prescription insulin drugs. Prohibits health insurance companies and other carriers from setting an amount exceeding $100 per 30-day supply that a covered person is required to pay at the point of sale in order to receive a covered prescription insulin drug. The measure also prohibits a provider contract between a carrier or its pharmacy benefits manager and a pharmacy from containing a provision (i) authorizing the carrier's pharmacy benefits manager or the pharmacy to charge, (ii) requiring the pharmacy to collect, or (iii) requiring a covered person to make a cost-sharing payment for a covered prescription insulin drug in an amount that exceeds such limitation.

AI Summary

This bill prohibits health insurance companies and other carriers from setting a cost-sharing payment (the amount a covered person pays at the point of sale) for a covered prescription insulin drug that exceeds $100 per 30-day supply. It also prohibits provider contracts between carriers or their pharmacy benefits managers and pharmacies from containing provisions that would allow or require the pharmacy to charge, collect, or have a covered person pay more than the $100 cost-sharing limit. The bill applies to health plans and provider contracts entered into, amended, extended, or renewed on or after January 1, 2021, and the State Corporation Commission may adopt regulations to implement the section.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Incorporated by Labor and Commerce (on 01/28/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...